Download Files:
BET-IN-16
SKU
HY-150268-Get quote
Category Reference compound
Tags Cancer, Epigenetic Reader Domain, Epigenetics
Products Details
Product Description
– BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 μM against LNCaP and 22Rv1 cells, respectively[1].
Web ID
– HY-150268
Shipping
– Room temperature
Molecular Formula
– C31H25N5O3
References
– [1]Ben Powell, et al. Combinational drug anticancer therapies. Patent, WO2022040512A1.
CAS Number
– 2089390-09-8
Molecular Weight
– 515.56
SMILES
– O=C(C1=CC=C(C2=CN(C(C3=NC=CC=C3)(C)C4=NC=CC=C4)C5=C2N=CC(C6=C(C)ON=C6C)=C5)C=C1)O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Epigenetic Reader Domain
Pathway
– Epigenetics
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.